Mitsuhide Ohmichi

1.0k total citations
31 papers, 740 citations indexed

About

Mitsuhide Ohmichi is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mitsuhide Ohmichi has authored 31 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 17 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Mitsuhide Ohmichi's work include Sarcoidosis and Beryllium Toxicity Research (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Medical Imaging and Pathology Studies (5 papers). Mitsuhide Ohmichi is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Medical Imaging and Pathology Studies (5 papers). Mitsuhide Ohmichi collaborates with scholars based in Japan. Mitsuhide Ohmichi's co-authors include Shosaku Abe, Noriharu Shijubo, Katsunori Shigehara, Hiroshi Tanaka, Ryuji Takahashi, Haruki Okamura, Masashi Kurimoto, Noriyuki Sato, Anne Pietinalho and Yomei Hiraga and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Mitsuhide Ohmichi

27 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuhide Ohmichi Japan 13 478 427 143 137 128 31 740
Brian M. Greenlee United States 7 572 1.2× 513 1.2× 191 1.3× 161 1.2× 162 1.3× 9 971
Katsunori Shigehara Japan 16 370 0.8× 337 0.8× 267 1.9× 221 1.6× 111 0.9× 31 863
J Guzman Germany 13 169 0.4× 456 1.1× 103 0.7× 99 0.7× 112 0.9× 33 667
Michio Shigematsu Japan 14 300 0.6× 658 1.5× 77 0.5× 85 0.6× 58 0.5× 29 814
Kotaro Kumano Japan 13 204 0.4× 200 0.5× 311 2.2× 61 0.4× 239 1.9× 20 820
Jan A. M. van Laar Netherlands 19 196 0.4× 267 0.6× 152 1.1× 217 1.6× 121 0.9× 43 891
Francesca Nencini Italy 17 252 0.5× 117 0.3× 396 2.8× 44 0.3× 86 0.7× 51 901
Guillermo Carrillo Mexico 13 326 0.7× 1.2k 2.7× 59 0.4× 105 0.8× 69 0.5× 24 1.3k
Meghan E. Free United States 10 342 0.7× 269 0.6× 526 3.7× 32 0.2× 93 0.7× 19 852
Glenda Trujillo United States 16 132 0.3× 456 1.1× 262 1.8× 100 0.7× 142 1.1× 20 820

Countries citing papers authored by Mitsuhide Ohmichi

Since Specialization
Citations

This map shows the geographic impact of Mitsuhide Ohmichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuhide Ohmichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuhide Ohmichi more than expected).

Fields of papers citing papers by Mitsuhide Ohmichi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuhide Ohmichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuhide Ohmichi. The network helps show where Mitsuhide Ohmichi may publish in the future.

Co-authorship network of co-authors of Mitsuhide Ohmichi

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuhide Ohmichi. A scholar is included among the top collaborators of Mitsuhide Ohmichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuhide Ohmichi. Mitsuhide Ohmichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shigehara, Katsunori, Noriharu Shijubo, Mitsuhide Ohmichi, et al.. (2003). Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clinical & Experimental Immunology. 132(1). 152–157. 51 indexed citations
2.
Hosono, Makoto, Toru Matsui, N. Honda, et al.. (2002). Non-invasive quantitative monitoring of cerebral blood flow in aneurysmal subarachnoid haemorrhage with 99mTc-ECD. Nuclear Medicine Communications. 23(1). 5–11. 7 indexed citations
3.
Ohmichi, Mitsuhide. (2002). [Histologic diagnosis of sarcoidosis].. PubMed. 60(9). 1759–65. 6 indexed citations
4.
Tanaka, Hiroshi, et al.. (2001). IL-18 might reflect disease activity in mild and moderate asthma exacerbation. Journal of Allergy and Clinical Immunology. 107(2). 331–336. 122 indexed citations
5.
Shijubo, Noriharu, Y. Itoh, Katsunori Shigehara, et al.. (2000). Association of Clara cell 10-kDa protein, spontaneous regression and sarcoidosis. European Respiratory Journal. 16(3). 414–414. 15 indexed citations
6.
Shigehara, Katsunori, Noriharu Shijubo, Mitsuhide Ohmichi, et al.. (2000). Increased Levels of Interleukin-18 in Patients with Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 162(5). 1979–1982. 59 indexed citations
7.
Tanaka, Hiroshi, et al.. (2000). Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma. Journal of Allergy and Clinical Immunology. 105(5). 900–905. 76 indexed citations
8.
Ohmichi, Mitsuhide, et al.. (2000). [Sarcoidosis associated with lupus pernio and acute pulmonary cavitation].. PubMed. 38(4). 307–11.
9.
Pietinalho, Anne, et al.. (2000). The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases.. PubMed. 17(2). 158–66. 51 indexed citations
10.
Tanaka, Hiroshi, et al.. (1999). Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients?. Respiratory Medicine. 93(12). 891–897. 9 indexed citations
11.
Pietinalho, Anne, et al.. (1999). Familial sarcoidosis in Finland and Hokkaido, Japan – a comparative study. Respiratory Medicine. 93(6). 408–412. 39 indexed citations
12.
Ohmichi, Mitsuhide, et al.. (1998). [Fulminant Mycoplasma pneumoniae pneumonia resulting in respiratory failure and a prolonged pulmonary lesion].. PubMed. 36(4). 374–80. 3 indexed citations
13.
Ohmichi, Mitsuhide, et al.. (1997). [Thymic carcinoma associated with pulmonary sarcoidosis].. PubMed. 35(5). 571–6. 1 indexed citations
14.
Kobayashi, Haruki, S. Kawai, Motohiro Tomizawa, et al.. (1996). Dose-finding study on NM441 in chronic respiratory tract infections. 44. 362–378. 1 indexed citations
15.
Shigehara, Katsunori, Noriharu Shijubo, Michio Hirasawa, et al.. (1995). Circulating γδ-T-Cell-Receptor-Positive Lymphocytes in Sarcoidosis. Respiration. 62(2). 84–88. 13 indexed citations
16.
Ohmichi, Mitsuhide, et al.. (1994). [Corticosteroid treatment in pulmonary sarcoidosis].. PubMed. 52(6). 1643–7. 1 indexed citations
17.
Shijubo, Noriharu, Koji Imai, Katsunori Shigehara, et al.. (1994). Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Clinical & Experimental Immunology. 95(1). 156–161. 35 indexed citations
18.
Saito, Atsushi, Hiroshi Fukuhara, Izuma Nakayama, et al.. (1992). Dose Finding Study of Cefepime for Chronic Respiratory Infections. Kansenshogaku zasshi. 66(7). 837–858. 2 indexed citations
19.
Asano, M, et al.. (1991). Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis. Clinical & Experimental Immunology. 84(1). 92–96. 41 indexed citations
20.
Ohmichi, Mitsuhide, et al.. (1988). Endobronchial Changes in Chronic Pulmonary Venous Hypertension. CHEST Journal. 94(6). 1127–1132. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026